Searchable abstracts of presentations at key conferences in endocrinology

ea0056oc14.2 | What is new in gestational and type 1 diabetes? | ECE2018

Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus

Papadopoulou Anna , Valsamakis George , Thymara Irini , Laryngaki Anastasia , Theodorou Spyridoula , Grammatopoulos Dimitris , Papaevangelou Vasiliki , Mastorakos George

The mammalian target of rapamycin (mTOR) is a serine kinase that couples energy and nutrient abundance to cell growth and is critically involved in the onset and progression of diabetes, cancer and ageing. Placental mTOR is involved in nutrient sensing and transfer to the fetus. Animal models suggest that placental mTOR is upregulated in pregnancies complicated by gestational diabetes (GDM). Our aim was to characterize expression, and cellular localization of mTOR and whether ...

ea0099ep255 | Calcium and Bone | ECE2024

An interesting case of co-existence of autosomal dominant hypocalcemia 1 with chronic myelogenous leukemia

Eleni Chondrogianni Maria , Kyrou Ioannis , Papadopoulou Anna , Kaperda Aikaterini , Diamantopoulos Panagiotis , Angelousi Anna , Randeva Harpal , Kassi Eva

Introduction: Autosomal dominant hypocalcemia (ADH) type 1 is a rare form of hypoparathyroidism, caused by heterozygous, inherited or de novo, activating mutations in the CASR. CASR is also expressed in the kidney and activating mutations lead to decreased calcium renal absorption. Activating mutations in the CasR, inhibits salt transport, leading to Bartteŕs syndrome (BS) type V which can co-exist with ADH1. Chronic myeloid leukemia (Cml) is characterized by the...